Veterinary Regenerative Medicine Market Size

Veterinary Regenerative Medicine Market Size

Veterinary Regenerative Medicine Market size was valued at USD 265.5 million in 2023 and is estimated to grow at 9.9% CAGR from 2024 to 2032, due to the increasing prevalence of chronic and degenerative diseases in animals. Conditions such as osteoarthritis, ligament injuries, and other age-related disorders are becoming more common in both companion and livestock animals.

To get key market trends

  Download Free Sample

For instance, according to the Companion Animal Health report, Osteoarthritis accounts for at least 80% of lameness and joint disease cases in companion animals. While osteoarthritis is often linked with older animals, a recent study on its prevalence and clinical signs in young dogs (aged 8 months to 4 years) revealed that 39.8% of these animals exhibited radiographic signs of osteoarthritis in at least one joint.
 

This highlighted the significant impact of osteoarthritis across various age groups in companion animals, underscoring the need for effective treatments and early intervention strategies. Moreover, growing awareness among pet owners and farmers about advanced treatment options drives demand for regenerative medicine, thereby fostering the market growth.
 

Veterinary regenerative medicine refers to the commercial development and application of advanced therapies to tissue repair, replace, or regenerate damaged tissues and organs in animals. This field utilizes cutting-edge techniques such as stem cell therapy, biological therapy includes platelet-rich plasma (PRP), growth factors, and tissue engineering to treat various conditions, including orthopedic injuries, soft tissue damage, and chronic diseases.